Is ChatGPT Ready for Public Use in Organ-Specific Drug Toxicity Research?

被引:0
|
作者
Connor, Skylar [1 ]
Wu, Leihong [1 ]
Roberts, Ruth A. [2 ,3 ]
Tong, Weida [1 ]
机构
[1] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[2] ApconiX Ltd, Alderley Pk, Alderley Edge SK10 4TG, England
[3] Univ Birmingham, Birmingham B15 2TT, England
关键词
GPT-4; Organ Toxicity; Public Health; Prompt Engineering; Artificial Intelligence (AI); Large Language Models (LLMs); Drug Toxicity and Safety; Liver; Heart; Kidney;
D O I
10.1016/j.drudis.2025.104297
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The growing impact of large language models (LLMs), such as ChatGPT, prompts questions about the reliability of their application in public health. We compared drug toxicity assessments by GPT-4 for liver, heart, and kidney against expert assessments using US Food and Drug Administration (FDA) drug- labeling documents. Two approaches were assessed: a 'General prompt', mimicking the conversational style used by the general public, and an 'Expert prompt' engineered to represent an approach of an expert. The Expert prompt achieved higher accuracy (64-75%) compared with the General prompt (48- 72%), but the overall performance was moderate, indicating that caution is needed when using GPT-4 for public health. To improve reliability, an advanced framework,such as Retrieval Augmented Generation (RAG), might be required to leverage knowledge embedded in GPT-4.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] ORGAN-SPECIFIC CHLOROFORM TOXICITY IN MICE - RELATIONSHIPS TO XENOBIOTIC METABOLISM, GLUTATHIONE DEPLETION AND COVALENT BINDING TO MICROSOMAL PROTEIN
    KLUWE, WM
    HOOK, JB
    PHARMACOLOGIST, 1978, 20 (03): : 259 - 259
  • [42] Immunomodulatory drug discovery from herbal medicines: Insights from organ-specific activity and xenobiotic defenses
    Shi, Jue
    Weng, Jui-Hsia
    Mitchison, Timothy J.
    ELIFE, 2021, 10
  • [43] THE USE OF TWO-DIMENSIONAL GEL-ELECTROPHORESIS IN THE ANALYSIS OF ORGAN-SPECIFIC MAIZE PROTEINS
    GODAY, A
    TORRENT, M
    LUDEVID, MD
    PUIGDOMENECH, P
    ELECTROPHORESIS, 1988, 9 (11) : 738 - 741
  • [44] Organ-specific toxicity of Romidepsin in patients with pre-existing cardiac, renal, and hepatic disease: A retrospective analysis
    Stonesifer, C.
    Khaleel, A.
    Amengual, J.
    Geskin, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S74 - S74
  • [45] Organ-specific manganese toxicity:: a comparative in vitro study on five cellular models exposed to MnCl2
    Rovetta, F.
    Catalani, S.
    Steimberg, N.
    Bonlottl, J.
    Gilberti, M. E.
    Mariggio, M. A.
    Mazzoleni, G.
    TOXICOLOGY IN VITRO, 2007, 21 (02) : 284 - 292
  • [46] "Safe" Chitosan/Zinc Oxide Nanocomposite Has Minimal Organ-Specific Toxicity in Early Stages of Zebrafish Development
    Younes, Nadin
    Pintus, Gianfranco
    Al-Asmakh, Maha
    Rasool, Kashif
    Younes, Salma
    Calzolari, Simone
    Mahmoud, Khaled A.
    Nasrallah, Gheyath K.
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (01): : 38 - 47
  • [47] Use of Organ-Specific Chimeric Antigen Receptor Promotes Liver Recruitment of Regulatory T Cells.
    Landmann, E.
    Ruiz, P.
    Ruiz, P.
    Kurt, A.
    Kodela, E.
    Martinez-Llordella, M.
    Sanchez-Fueyo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 586 - 586
  • [48] Differential sensitivity of rat kidney and liver to fumonisin toxicity: Organ-specific differences in toxin accumulation and sphingoid base metabolism
    Riley, Ronald T.
    Voss, Kenneth A.
    TOXICOLOGICAL SCIENCES, 2006, 92 (01) : 335 - 345
  • [49] Spatiotemporal Heterogeneity across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer
    Zhou, Jiawei
    Li, Quefeng
    Cao, Yanguang
    CANCER RESEARCH, 2021, 81 (09) : 2522 - 2533
  • [50] Liposomal drug delivery systems for organ-specific cancer targeting: early promises, subsequent problems, and recent breakthroughs
    Zahednezhad, Fahimeh
    Allahyari, Saeideh
    Sarfraz, Muhammad
    Zakeri-Milani, Parvin
    Feyzizadeh, Mohammad
    Valizadeh, Hadi
    EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (09) : 1363 - 1384